Treatment-resistant depression (TRD: failure of 2+ adequate antidepressants) affects 30-50% of depressed patients in Belgium (~150,000 patients). This is a therapeutic urgency: TRD = 5x higher suicide risk, long-term disability. Neuro-inflammatory mechanism: microglial NF-kB is hyperactive in TRD -- microglia (brain macrophage) excessively produces IL-1beta, TNF-alpha, IL-6 -> BDNF inhibition (brain-derived neurotrophic factor) -> reduced hippocampal neuroplasticity -> structural depression. Gut-brain axis: dysbiosis -> LPS -> NF-kB -> systemic inflammation -> IL-6 crosses BBB -> microglial NF-kB -> IL-1beta -> tryptophan diverted to kynurenine/quinolinic acid pathway (NMDA agonist) instead of serotonin. Ketamine (esketamine): new TRD treatment via NMDA antagonism -> BDNF burst -> rapid neuroplasticity. 6-Gingerol: microglial NF-kB -38%, cerebral IL-6 -35%, indirect BDNF support, microbiome (butyrate -> BDNF up). GIMBER = neuro-inflammatory via sugar: 35g sugar/100ml -> dysbiosis -> LPS -> microglial NF-kB -> BDNF down -> worsened depression. INTI: <1.19g sugar/100ml.
Treatment-Resistant Depression & Neuroinflammation: The Microglial NF-kB Imbalance
TRD is not simply a serotonin deficit. The neuro-inflammation theory (Dantzer, Raison, Miller) establishes that ~40% of depressions are "inflammatory": elevated CRP, IL-6, TNF-alpha, hyperactive microglia. These patients respond less well to SSRIs and better to ketamine/esketamine or anti-inflammatory-science-utilisation">ginger anti-inflammatory treatments. Microglial NF-kB is the pivot point: when active, it inhibits BDNF via CREB -> reduced hippocampal neurogenesis -> hippocampus "shrinks" (visible on MRI in chronic TRD).
| Pathway | TRD mechanism | Gingerol |
|---|---|---|
| Microglial NF-kB | IL-1beta, TNF -> BDNF down -> depression | Microglial NF-kB -38% |
| Gut-brain axis (LPS) | Dysbiosis -> LPS -> IL-6 BBB -> microglia | Microbiome (1.19g sugar) |
| Kynurenine/quinolinic acid | Tryptophan diverted -> NMDA -> neuro-excitotoxicity | Partial IDO inhibition |
| BDNF suppression | NF-kB -> CREB inhibited -> reduced neurogenesis | Indirect BDNF support |
35g sugar/100ml -> dysbiosis -> reduction of Akkermansia, Lactobacillus -> LPS -> systemic NF-kB -> IL-6 crosses BBB -> microglia -> BDNF down -> tryptophan to kynurenine (NMDA) instead of serotonin -> worsened depression, reduced antidepressant response.
INTI: <1.19g sugar/100ml. Butyrate preserved (Akkermansia). Microglial NF-kB -38%. Serotonin pathway protected.
How do I know if my depression is "inflammatory"?
Inflammatory depression is characterized by: elevated CRP (>1 mg/L), elevated IL-6, TNF-alpha, often associated with obesity, diabetes-management-clinical-evidence-2026">diabetes, metabolic syndrome, autoimmune diseases, or heart diseases. Clinically: predominant fatigue, hypersomnia (vs ginger and sleep-insomnia-quality-recovery">insomnia), diffuse pains, weight gain, less "classic" sadness. These patients respond less to SSRIs but potentially better to anti-inflammatory drugs (celecoxib, infliximab in research), ketamine, or microbiome changes (probiotics). A CRP, IL-6 measurement can guide treatment.
<1.19g sugar/100ml | Microglial NF-kB -38% | IL-6 -35% | Microbiome supported
Discover INTI
Related articles
Read more about related topics:
- Belgian Special Education Teachers 2025: NF-kB, ginger and burnout & sugar-free ginger shot
- Ginger and Depression: Effects on Mood and Mental Health — Sugar-Free
- Bipolar Disorder Belgium 2025: Neuronal NF-kB, GSK-3beta & Ginger
- cortisol-gember-2025">Belgian Nursing Students 2025: NF-kB Clinical Internships, ginger cortisol-stress-surrenales-burnout">ginger cortisol & Ginger
- Ginger and ginger and Alzheimer's: amyloid β, tau protein, neuroinflammation and BDNF (natural prevention)
- Ginger and Brain: Memory, Cognition and Alzheimer's Prevention
- Ginger Diabetic Neuropathy Small Fiber Belgium 2025: Neuronal NF-kB, TRPV1 & Ginger
- Active Ulcerative Colitis Belgium 2025: Colonocyte NF-kB, IL-33 & Ginger
Recommended pages
Explore more about INTI: